NCT01713647View on ClinicalTrials.gov

Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Fasting
Interventions
DRUG

Amlodipin, losartan, HCTZ

Trial Locations (1)

1084

Pharmaceutical research unit, Amman

Sponsors
All Listed Sponsors
lead

Pharmaceutical Research Unit, Jordan

OTHER